2022
Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy
Al’Aref S, Altibi A, Malkawi A, Mansour M, Baskaran L, Masri A, Rahmouni H, Abete R, Andreini D, Aquaro G, Barison A, Bogaert J, Camastra G, Carigi S, Carrabba N, Casavecchia G, Censi S, Cicala G, Conte E, De Cecco C, De Lazzari M, Di Giovine G, Di Roma M, Dobrovie M, Focardi M, Gaibazzi N, Gismondi A, Gravina M, Guglielmo M, Lanzillo C, Lombardi M, Lorenzoni V, Lozano-Torres J, Margonato D, Martini C, Marzo F, Masci P, Masi A, Memeo R, Moro C, Mushtaq S, Nese A, Palumbo A, Pavon A, Pedrotti P, Pepi M, Marra M, Pica S, Pradella S, Presicci C, Rabbat M, Raineri C, Rodriguez-Palomares J, Sbarbati S, Schoepf U, Squeri A, Sverzellati N, Symons R, Tat E, Timpani M, Todiere G, Valentini A, Varga-Szemes A, Volpe A, Fusini L, Guaricci A, Schwitter J, Pontone G. Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy. European Heart Journal - Cardiovascular Imaging 2022, 24: 472-482. PMID: 35792682, PMCID: PMC10029842, DOI: 10.1093/ehjci/jeac124.Peer-Reviewed Original ResearchConceptsRight ventricular systolic dysfunctionCardiac magnetic resonanceAll-cause mortalityPredictor of all-cause mortalityRV ejection fractionPrognostic valueEjection fractionSystolic dysfunctionHeart failureQuantitative assessment of RV functionMean left ventricular ejection fractionAssessment of RV functionBaseline cardiac magnetic resonanceRV systolic dysfunctionRV systolic functionMedian follow-upNormal renal functionVentricular systolic dysfunctionVentricular ejection fractionReduced ejection fractionKaplan-Meier curvesRV functionNYHA III/IVSystolic functionRenal dysfunction
2019
Cardiac Dysfunction Among People Living With HIV A Systematic Review and Meta-Analysis
Erqou S, Lodebo B, Masri A, Altibi A, Echouffo-Tcheugui J, Dzudie A, Ataklte F, Choudhary G, Bloomfield G, Wu W, Kengne A. Cardiac Dysfunction Among People Living With HIV A Systematic Review and Meta-Analysis. JACC Heart Failure 2019, 7: 98-108. PMID: 30704613, DOI: 10.1016/j.jchf.2018.10.006.Peer-Reviewed Original ResearchMeSH KeywordsCardiomyopathiesGlobal HealthHIVHIV InfectionsHumansIncidenceRisk FactorsVentricular FunctionConceptsLeft ventricular systolic dysfunctionPrevalence of left ventricular systolic dysfunctionHuman immunodeficiency virusCardiac dysfunctionRisk of human immunodeficiency virusPrevalence of pulmonary hypertensionHuman immunodeficiency virus infectionRight ventricular dysfunctionAntiretroviral therapy useClinical heart failureVentricular systolic dysfunctionImmune deficiency syndromeRandom-effects model meta-analysesMeta-analysesStudy level characteristicsStudy-specific estimatesPulmonary hypertensionSystolic dysfunctionVentricular dysfunctionImmunodeficiency virusPooled incidenceDilated cardiomyopathyGrade IIGrade ITherapy use